Thus, these data suggest that the primary tumor was in-effect spatially heterogeneous, containing a minor reservoir of TERT mutant, chr10 lost, chr7 gain, MET non-amplified precursor cells that escape targeted therapy. This evidence concerns the gene MET and neoplasm.